Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Short term Debt (2024 - 2025)

Historic Short term Debt for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $4.3 million.

  • Kura Oncology's Short term Debt rose 15288.63% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 15288.63%. This contributed to the annual value of $2.6 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Kura Oncology reported Short term Debt of $4.3 million as of Q3 2025, which was up 15288.63% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Short term Debt ranged from a high of $4.3 million in Q3 2025 and a low of $847000.0 during Q2 2024